Skip to main content

Human papillomavirus (HPV) vaccine hesitancy trends in the United States.

Conferences
Boakye, EA; Abouelella, DK; Nair, M; Osazuwa-Peters, N
Published in: JOURNAL OF CLINICAL ONCOLOGY
June 1, 2022

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

JOURNAL OF CLINICAL ONCOLOGY

EISSN

1527-7755

ISSN

0732-183X

Publication Date

June 1, 2022

Volume

40

Issue

16

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Boakye, E. A., Abouelella, D. K., Nair, M., & Osazuwa-Peters, N. (2022). Human papillomavirus (HPV) vaccine hesitancy trends in the United States. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 40).
Boakye, Eric Adjei, Dina K. Abouelella, Mrudula Nair, and Nosayaba Osazuwa-Peters. “Human papillomavirus (HPV) vaccine hesitancy trends in the United States.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 40, 2022.
Boakye EA, Abouelella DK, Nair M, Osazuwa-Peters N. Human papillomavirus (HPV) vaccine hesitancy trends in the United States. In: JOURNAL OF CLINICAL ONCOLOGY. 2022.
Boakye, Eric Adjei, et al. “Human papillomavirus (HPV) vaccine hesitancy trends in the United States.JOURNAL OF CLINICAL ONCOLOGY, vol. 40, no. 16, 2022.
Boakye EA, Abouelella DK, Nair M, Osazuwa-Peters N. Human papillomavirus (HPV) vaccine hesitancy trends in the United States. JOURNAL OF CLINICAL ONCOLOGY. 2022.

Published In

JOURNAL OF CLINICAL ONCOLOGY

EISSN

1527-7755

ISSN

0732-183X

Publication Date

June 1, 2022

Volume

40

Issue

16

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis